Co-founder of The Carlyle Group, David Rubenstein, speaks with Jennifer Doudna, a Nobel laureate and professor at the University of California, Berkeley, about the moral and ethical implications of advancements in genetic editing technology and the importance of keeping an open mind towards scientific exploration.